Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pützer

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Folia Phoniatrica Et Logopaedica : Official Organ of the International Association of Logopedics and Phoniatrics (IALP)|March 13, 2001
[Multiparametric description of voice quality for normal male and female voices]M Pützer
Journal of Cellular and Molecular Medicine|May 10, 2007
E2F1 death pathways as targets for cancer therapyB M Pützer
Oncotarget|January 9, 2014
DNp73: oncotarget in invasion and metastasisBrigitte M Pützer
Discovery Medicine|January 20, 2007
Targeting E2F1 death signaling: opposing role in cancer control and neurodegenerationBrigitte M Pützer
Laryngo- Rhino- Otologie|February 25, 2006
[Multiparametric description of voice quality for normal male and female voices based on acoustic analyses]M Pützer, W Wokurek
Laryngo- Rhino- Otologie|September 26, 2014
[Acoustic- and EGG-parametrisations of Phonatory Quality Provide Voice Profiles of Normal Speakers]M Pützer, W Wokurek
Nature Clinical Practice. Oncology|October 5, 2006
Mechanisms of Disease: cancer targeting and the impact of oncogenic RET for medullary thyroid carcinoma therapyMatthias Drosten, Brigitte M Pützer
Trends in Molecular Medicine|March 15, 2006
E2F1-induced apoptosis: turning killers into therapeuticsJens Stanelle, Brigitte M Pützer
Trends in Molecular Medicine|July 10, 2004
The RET proto-oncogene: a potential target for molecular cancer therapyBrigitte M Pützer, Matthias Drosten
Cell Cycle (Georgetown, Tex.)|June 29, 2010
Checks and balances: E2F-microRNA crosstalk in cancer controlStephan Emmrich, Brigitte M Pützer
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Folia Phoniatrica Et Logopaedica : Official Organ of the International Association of Logopedics and Phoniatrics (IALP)|March 13, 2001
[Multiparametric description of voice quality for normal male and female voices]M Pützer
Journal of Cellular and Molecular Medicine|May 10, 2007
E2F1 death pathways as targets for cancer therapyB M Pützer
Oncotarget|January 9, 2014
DNp73: oncotarget in invasion and metastasisBrigitte M Pützer
Discovery Medicine|January 20, 2007
Targeting E2F1 death signaling: opposing role in cancer control and neurodegenerationBrigitte M Pützer
Laryngo- Rhino- Otologie|February 25, 2006
[Multiparametric description of voice quality for normal male and female voices based on acoustic analyses]M Pützer, W Wokurek
Laryngo- Rhino- Otologie|September 26, 2014
[Acoustic- and EGG-parametrisations of Phonatory Quality Provide Voice Profiles of Normal Speakers]M Pützer, W Wokurek
Nature Clinical Practice. Oncology|October 5, 2006
Mechanisms of Disease: cancer targeting and the impact of oncogenic RET for medullary thyroid carcinoma therapyMatthias Drosten, Brigitte M Pützer
Trends in Molecular Medicine|March 15, 2006
E2F1-induced apoptosis: turning killers into therapeuticsJens Stanelle, Brigitte M Pützer
Trends in Molecular Medicine|July 10, 2004
The RET proto-oncogene: a potential target for molecular cancer therapyBrigitte M Pützer, Matthias Drosten
Cell Cycle (Georgetown, Tex.)|June 29, 2010
Checks and balances: E2F-microRNA crosstalk in cancer controlStephan Emmrich, Brigitte M Pützer
Pageof 13